SCHEMBL19432575

SCHEMBL19432575

O=C(Nc1ccc2oc(-c3ccccc3)nc2c1)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.76
MAPT P10636 13/20 0.74
ALDH1A1 P00352 5/20 0.74
SMN1; SMN2 Q16637 4/20 0.74
LMNA P02545 2/20 0.74
TSHR P16473 2/20 0.74
POLB P06746 2/20 0.74
MAPK1 P28482 1/20 0.74
THRB P10828 2/20 0.72
KDM4E B2RXH2 4/20 0.71
RXFP1 Q9HBX9 3/20 0.71
NPSR1 Q6W5P4 1/20 0.71
NPC1 O15118 3/20 0.67
RAB9A P51151 3/20 0.67
USP2 O75604 2/20 0.67
MEN1 O00255 1/20 0.66
HPGD P15428 1/20 0.66
KMT2A Q03164 1/20 0.66
HSD17B10 Q99714 1/20 0.66
PTGS2 P35354 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2247470 0.90 MAPT (0.89) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL2245512 0.90 MAPT (0.82) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL2247199 0.90 MAPT (0.86) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL2244745 0.86 MAPT (0.87) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL2243823 0.86 MAPT (0.77) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL2245527 0.86 TP53 (1.00) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL2240507 0.86 MAPT (0.87) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL2245519 0.85 ALDH1A1 (1.00) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL2242829 0.84 MAPT (0.78) TP53MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL19428467 0.84 MAPT (0.74) TP53MAPTALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, FABP7 TP53 743/4885MAPT 7/4885ALDH1A1 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.